EUVIMEDEUVIMED entdecken
Fallbericht

Dual TERT promoter mutations in glioblastoma, IDH-wildtype: a case report with preclinical investigations

Yohei Miyake, Kensuke Tateishi, Hinako Okagawa, Akihide Koyama, Emi Hirata, Kanoko Sasaoka, Shuna Saito, Shuto Fushimi, Manabu Natsumeda, Erika Muraoka, Shoji Yamanaka, Satoshi Fujii und 1 weitere

Brain Tumor Pathology · 21.05.2026

DOI: 10.1007/s10014-026-00540-8 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Brain Tumor Pathology, online erschienen am 21.05.2026. Verfasst von Yohei Miyake und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telomerase reverse transcriptase promoter (TERTp) mutations c.-124C > T (C228T) and c.-146C > T (C250T) are the most frequent single-nucleotide variants promoting telomerase activation in glioblastoma. Here, we describe a rare case of glioblastoma IDH-wildtype with dual TERTp mutations. Genomic analyses of multiregional tumor samples revealed co-occurring TERT C228T and C250T mutations across tumor regions, with variable copy number alterations of EGFR and CDKN2A. Notably, only the TERTp C228T mutation was retained in the corresponding patient-derived xenograft, accompanied by more extensive copy number alterations, implying a selective growth advantage for the TERT C228T-harboring subclone during tumor propagation in this case. These findings suggest that dual TERTp mutations may arise through subclonal evolutionary processes in glioblastoma and highlight telomere maintenance as a dynamic, heterogeneous process rather than invariably representing a fixed early oncogenic event.

Schlagwörter

Stichwörter der Autor:innen

Dual TERT promoter mutationsPatient-derived xenograft modelSubclone

Autor:innen und Institutionen

  • Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan.
  • Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan. ktate12@yokohama-cu.ac.jp.
  • Laboratory of Biopharmaceutical and Regenerative Science, Graduate School of Medical Science, Yokohama City University, Yokohama, Japan. ktate12@yokohama-cu.ac.jp.
  • Laboratory of Biopharmaceutical and Regenerative Science, Graduate School of Medical Science, Yokohama City University, Yokohama, Japan.
  • Department of Legal Medicine, Graduate School of Medical and Dental Science, Niigata University, Niigata, Japan.
  • Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Miyake, Y., Tateishi, K., Okagawa, H., Koyama, A., Hirata, E., Sasaoka, K., Saito, S., Fushimi, S., Natsumeda, M., Muraoka, E., Yamanaka, S., Fujii, S., & Yamamoto, T. (2026). Dual TERT promoter mutations in glioblastoma, IDH-wildtype: a case report with preclinical investigations. Brain Tumor Pathology. https://doi.org/10.1007/s10014-026-00540-8

Vancouver

Miyake Y, Tateishi K, Okagawa H, Koyama A, Hirata E, Sasaoka K, et al. Dual TERT promoter mutations in glioblastoma, IDH-wildtype: a case report with preclinical investigations. Brain Tumor Pathology. 2026. doi:10.1007/s10014-026-00540-8

BibTeX
@article{Miyake2026,
  author = {Miyake, Yohei and Tateishi, Kensuke and Okagawa, Hinako and Koyama, Akihide and Hirata, Emi and Sasaoka, Kanoko and Saito, Shuna and Fushimi, Shuto and Natsumeda, Manabu and Muraoka, Erika and Yamanaka, Shoji and Fujii, Satoshi and Yamamoto, Tetsuya},
  title = {Dual TERT promoter mutations in glioblastoma, IDH-wildtype: a case report with preclinical investigations},
  journal = {Brain Tumor Pathology},
  year = {2026},
  doi = {10.1007/s10014-026-00540-8}
}
Kostenlos starten →